{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:27:07Z","timestamp":1788121627875,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11030-024-10936-3","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T11:02:16Z","timestamp":1721214136000},"page":"1619-1639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Repurposing of FDA-approved drugs against oligomerization domain of dengue virus NS1 protein: a computational approach"],"prefix":"10.1007","volume":"29","author":[{"given":"Dwaipayan","family":"Chaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyabrata","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-2612","authenticated-orcid":false,"given":"Kalyan","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"issue":"7","key":"10936_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/life11070615","volume":"11","author":"R Zhao","year":"2021","unstructured":"Zhao R, Wang M, Cao J, Shen J, Zhou X, Wang D, Cao J (2021) Flavivirus: from structure to therapeutics development. Life 11(7):615. https:\/\/doi.org\/10.3390\/life11070615","journal-title":"Life"},{"issue":"1","key":"10936_CR2","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1080\/21505594.2021.1996059","volume":"12","author":"SW van Leur","year":"2021","unstructured":"van Leur SW, Heunis T, Munnur D, Sanyal S (2021) Pathogenesis and virulence of flavivirus infections. Virulence 12(1):2814\u20132838. https:\/\/doi.org\/10.1080\/21505594.2021.1996059","journal-title":"Virulence"},{"issue":"1","key":"10936_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12929-018-0462-0","volume":"25","author":"HR Chen","year":"2018","unstructured":"Chen HR, Lai YC, Yeh TM (2018) Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate. J Biomed Sci 25(1):58. https:\/\/doi.org\/10.1186\/s12929-018-0462-0","journal-title":"J Biomed Sci"},{"issue":"1","key":"10936_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mjafi.2014.09.011","volume":"71","author":"MS Mustafa","year":"2015","unstructured":"Mustafa MS, Rasotgi V, Jain S, Gupta V (2015) Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control. Med J Armed Forces India 71(1):67\u201370. https:\/\/doi.org\/10.1016\/j.mjafi.2014.09.011","journal-title":"Med J Armed Forces India"},{"issue":"4","key":"10936_CR5","doi-asserted-by":"publisher","first-page":"e01985-18","DOI":"10.1128\/JVI.01985-18","volume":"93","author":"R Rosales Ramirez","year":"2019","unstructured":"Rosales Ramirez R, Ludert JE (2019) The dengue virus nonstructural protein 1 (NS1) is secreted from mosquito cells in association with the intracellular cholesterol transporter chaperone caveolin complex. J Virol 93(4):e01985-18. https:\/\/doi.org\/10.1128\/JVI.01985-18","journal-title":"J Virol"},{"issue":"3","key":"10936_CR6","doi-asserted-by":"publisher","first-page":"msad33","DOI":"10.1093\/molbev\/msad033","volume":"40","author":"A Sharma","year":"2023","unstructured":"Sharma A, Krishna S, Sowdhamini R (2023) Bioinformatics analysis of mutations sheds light on the evolution of dengue NS1 protein with implications in the identification of potential functional and druggable sites. Mol Biol Evol 40(3):msad33. https:\/\/doi.org\/10.1093\/molbev\/msad033","journal-title":"Mol Biol Evol"},{"issue":"5","key":"10936_CR7","doi-asserted-by":"publisher","first-page":"e1007736","DOI":"10.1371\/journal.ppat.1007736","volume":"15","author":"A P\u0142aszczyca","year":"2019","unstructured":"P\u0142aszczyca A, Scaturro P, Neufeldt CJ, Cortese M, Cerikan B, Ferla S, Brancale A, Pichlmair A, Bartenschlager R (2019) A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle. PLoS Pathog 15(5):e1007736. https:\/\/doi.org\/10.1371\/journal.ppat.1007736","journal-title":"PLoS Pathog"},{"issue":"14","key":"10936_CR8","doi-asserted-by":"publisher","first-page":"e00275-18","DOI":"10.1128\/JVI.00275-18","volume":"92","author":"AC Alcal\u00e1","year":"2018","unstructured":"Alcal\u00e1 AC, Palomares LA, Ludert JE (2018) Secretion of nonstructural protein 1 of dengue virus from infected mosquito cells: facts and speculations. J Virol 92(14):e00275-18. https:\/\/doi.org\/10.1128\/JVI.00275-18","journal-title":"J Virol"},{"issue":"5","key":"10936_CR9","doi-asserted-by":"publisher","first-page":"e0144123","DOI":"10.1128\/mbio.01441-23","volume":"14","author":"S Denolly","year":"2023","unstructured":"Denolly S, Guo H, Martens M, P\u0142aszczyca A, Scaturro P, Prasad V, Kongmanas K, Punyadee N, Songjaeng A, Mairiang D, Pichlmair A, Avirutnan P, Bartenschlager R (2023) Dengue virus NS1 secretion is regulated via importin-subunit \u03b21 controlling expression of the chaperone GRp78 and targeted by the clinical drug ivermectin. MBio 14(5):e0144123. https:\/\/doi.org\/10.1128\/mbio.01441-23","journal-title":"MBio"},{"issue":"11","key":"10936_CR10","doi-asserted-by":"publisher","first-page":"e1006673","DOI":"10.1371\/journal.ppat.1006673","volume":"13","author":"DR Glasner","year":"2017","unstructured":"Glasner DR, Ratnasiri K, Puerta-Guardo H, Espinosa DA, Beatty PR, Harris E (2017) Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. PLoS Pathog 13(11):e1006673. https:\/\/doi.org\/10.1371\/journal.ppat.1006673","journal-title":"PLoS Pathog"},{"issue":"3","key":"10936_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/imm.12748","volume":"151","author":"GN Malavige","year":"2017","unstructured":"Malavige GN, Ogg GS (2017) Pathogenesis of vascular leak in dengue virus infection. Immunology 151(3):261\u2013269. https:\/\/doi.org\/10.1111\/imm.12748","journal-title":"Immunology"},{"issue":"1","key":"10936_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","volume":"5","author":"DR Glasner","year":"2018","unstructured":"Glasner DR, Puerta-Guardo H, Beatty PR, Harris E (2018) The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis. Annu Rev Virol 5(1):227\u2013253. https:\/\/doi.org\/10.1146\/annurev-virology-101416-041848","journal-title":"Annu Rev Virol"},{"issue":"4","key":"10936_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007625","volume":"15","author":"CH Chao","year":"2019","unstructured":"Chao CH, Wu WC, Lai YC, Tsai PJ, Perng GC, Lin YS, Yeh TM (2019) Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog 15(4):e1007625. https:\/\/doi.org\/10.1371\/journal.ppat.1007625","journal-title":"PLoS Pathog"},{"issue":"10","key":"10936_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077453","volume":"8","author":"A Kumar","year":"2013","unstructured":"Kumar A, Rajendran V, Sethumadhavan R, Purohit R (2013) Molecular dynamic simulation reveals damaging impact of RAC1 F28L mutation in the switch I region. PLoS ONE 8(10):e77453. https:\/\/doi.org\/10.1371\/journal.pone.0077453","journal-title":"PLoS ONE"},{"issue":"3","key":"10936_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/07391102.2020.1720818","volume":"39","author":"J Sharma","year":"2021","unstructured":"Sharma J, Bhardwaj VK, Das P, Purohit R (2021) Identification of naturally originated molecules as \u03b3-aminobutyric acid receptor antagonist. J Biomol Struct Dyn 39(3):911\u2013922. https:\/\/doi.org\/10.1080\/07391102.2020.1720818","journal-title":"J Biomol Struct Dyn"},{"issue":"17","key":"10936_CR16","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1080\/07391102.2021.1900918","volume":"40","author":"R Singh","year":"2022","unstructured":"Singh R, Bhardwaj VK, Sharma J, Das P, Purohit R (2022) Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration. J Biomol Struct Dyn 40(17):7693\u20137701. https:\/\/doi.org\/10.1080\/07391102.2021.1900918","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"10936_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2174\/1386207319666160506123715","volume":"19","author":"CN Powers","year":"2016","unstructured":"Powers CN, Setzer WN (2016) An in-silico investigation of phytochemicals as antiviral agents against dengue fever. Comb Chem High Throughput Screen 19(7):516\u2013536. https:\/\/doi.org\/10.2174\/1386207319666160506123715","journal-title":"Comb Chem High Throughput Screen"},{"issue":"19","key":"10936_CR18","doi-asserted-by":"publisher","first-page":"11131","DOI":"10.3390\/ijms231911131","volume":"23","author":"MK Dassanayake","year":"2022","unstructured":"Dassanayake MK, Khoo TJ, Chong CH, Di Martino P (2022) Molecular docking and in-silico analysis of natural biomolecules against dengue, ebola, zika, SARS-CoV-2 variants of concern and monkeypox virus. Int J Mol Sci 23(19):11131. https:\/\/doi.org\/10.3390\/ijms231911131","journal-title":"Int J Mol Sci"},{"key":"10936_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10716-5","author":"SH Rashmi","year":"2023","unstructured":"Rashmi SH, Disha KS, Sudheesh N, Karunakaran J, Joseph A, Jagadesh A, Mudgal PP (2023) Repurposing of approved antivirals against dengue virus serotypes: an in silico and in vitro mechanistic study. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-023-10716-5","journal-title":"Mol Divers"},{"issue":"11","key":"10936_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300292","volume":"356","author":"HN Saleem","year":"2023","unstructured":"Saleem HN, Kousar S, Jiskani AH, Sohail I, Faisal A, Saeed M (2023) Repurposing of investigational cancer drugs: early phase discovery of dengue virus NS2B\/NS3 protease inhibitors. Arch Pharm (Weinheim) 356(11):e2300292. https:\/\/doi.org\/10.1002\/ardp.202300292","journal-title":"Arch Pharm (Weinheim)"},{"issue":"1","key":"10936_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10936_CR22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1021\/ci5006004","volume":"55","author":"A Borrel","year":"2015","unstructured":"Borrel A, Regad L, Xhaard H, Petitjean M, Camproux A (2015) PockDrug: a model for predicting pocket druggability that overcomes pocket estimation uncertainties. J Chem Inf Model 55(4):882\u2013895. https:\/\/doi.org\/10.1021\/ci5006004","journal-title":"J Chem Inf Model"},{"issue":"W1","key":"10936_CR23","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian W, Chen C, Lei X, Zhao J, Liang J (2018) CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res 46(W1):W363\u2013W367. https:\/\/doi.org\/10.1093\/nar\/gky473","journal-title":"Nucleic Acids Res"},{"key":"10936_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/409658","volume":"2013","author":"K Wang","year":"2013","unstructured":"Wang K, Gao J, Shen S, Tuszynski JA, Ruan J, Hu G (2013) An accurate method for prediction of protein-ligand binding site on protein surface using SVM and statistical depth function. Biomed Res Int 2013:409658. https:\/\/doi.org\/10.1155\/2013\/409658","journal-title":"Biomed Res Int"},{"issue":"16","key":"10936_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26(16):1701\u20131718. https:\/\/doi.org\/10.1002\/jcc.20291","journal-title":"J Comput Chem"},{"key":"10936_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10834-8","author":"D Chaudhuri","year":"2024","unstructured":"Chaudhuri D, Majumder S, Giri K (2024) Repurposing of drugs targeting heparan sulphate binding site of dengue virus envelope protein: an in silico competitive binding study. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-024-10834-8","journal-title":"Mol Divers"},{"issue":"7","key":"10936_CR27","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Open Source Drug Discovery Consortium, Lynn A (2014) g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54(7):1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m","journal-title":"J Chem Inf Model"},{"issue":"D1","key":"10936_CR28","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 50: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074\u2013D1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10936_CR29","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S (2021) J Chem Inf Model 61(8):3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"issue":"W1","key":"10936_CR30","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, Peng J, Deng Y, Wang W, Wu C, Lyu A, Zeng X, Zhao W, Hou T, Cao D (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422\u2013W431. https:\/\/doi.org\/10.1093\/nar\/gkae236","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10936_CR31","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1021\/acs.jctc.8b00230","volume":"14","author":"DB Kokh","year":"2018","unstructured":"Kokh DB, Amaral M, Bomke J, Gradler U, Musil D, Buchstaller HP, Dreyer MK, Frech M, Lowinski M, Vallee F, Bianciotto M, Rak A, Wade RC (2018) Estimation of drug-target residence times by \u03c4-random acceleration molecular dynamics simulations. J Chem Theory Comput 14(7):3859\u20133869. https:\/\/doi.org\/10.1021\/acs.jctc.8b00230","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"10936_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40506-023-00263-w","volume":"15","author":"M Palanichamy Kala","year":"2023","unstructured":"Palanichamy Kala M, St John AL, Rathore APS (2023) Dengue: update on clinically relevant therapeutic strategies and vaccines. Curr Treat Options Infect Dis 15(2):27\u201352. https:\/\/doi.org\/10.1007\/s40506-023-00263-w","journal-title":"Curr Treat Options Infect Dis"},{"issue":"Pt 1","key":"10936_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/brain\/123.1.9","volume":"123","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P, Saxena PR, Dahlof C, Pascual J, Lainez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9\u201318","journal-title":"Brain"},{"key":"10936_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1099-4831(06)63002-2","volume":"63","author":"CL Schardl","year":"2006","unstructured":"Schardl CL, Panaccione DG, Tudzynski P (2006) Ergot alkaloids\u2013biology and molecular biology. Alkaloids Chem Biol 63:45\u201386","journal-title":"Alkaloids Chem Biol"},{"key":"10936_CR35","unstructured":"Eisenschink MA, Olson PT (1982) Fermentation process for producing natamycin. U.S. Patent US5231014"},{"issue":"4","key":"10936_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1172\/JCI102273","volume":"29","author":"JH Hafkenschiel","year":"1950","unstructured":"Hafkenschiel JH, Crumpton CW, Moyer JH, Jeffers WA, Fishel Hanley B, Conlin Harned S (1950) The effects of dihydroergocornine on the cerebral circulation of patients with essential hypertension. J Clin Invest 29(4):408\u2013411. https:\/\/doi.org\/10.1172\/JCI102273","journal-title":"J Clin Invest"},{"issue":"6 Pt 2","key":"10936_CR37","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1172\/JCI102204","volume":"28","author":"ED Freis","year":"1949","unstructured":"Freis ED, Stanton JR et al (1949) The hemodynamic effects of hypotensive drugs in man; dihydroergocornine. J Clin Invest 28(6 Pt 2):1387\u20131402. https:\/\/doi.org\/10.1172\/JCI102204","journal-title":"J Clin Invest"},{"issue":"4","key":"10936_CR38","first-page":"234","volume":"72","author":"NA Bercel","year":"1950","unstructured":"Bercel NA (1950) Treatment of migraine-results with dihydroergocornine methanesulfonate (DHO-180) and other ergot derivatives. Calif Med 72(4):234\u2013238","journal-title":"Calif Med"},{"issue":"4","key":"10936_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI102111","volume":"28","author":"DW Hayes","year":"1949","unstructured":"Hayes DW, Wakim KG, Horton BT, Peters GA (1949) The effects of dihydroergocornine on the circulation in the extremities of man. J Clin Invest 28(4):615\u2013620. https:\/\/doi.org\/10.1172\/JCI102111","journal-title":"J Clin Invest"},{"issue":"1","key":"10936_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1600-0404.1999.tb00655.x","volume":"99","author":"L Battistin","year":"1999","unstructured":"Battistin L, Bardin PG, Ferro-Milone F, Ravenna C, Toso V, Reboldi G (1999) Alpha-dihydroergocryptine in Parkinson\u2019s disease: a multicentre randomized double blind parallel group study. Acta Neurol Scand 99(1):36\u201342. https:\/\/doi.org\/10.1111\/j.1600-0404.1999.tb00655.x","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10936_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1476-5381.1982.tb09197.x","volume":"76","author":"JM Elliott","year":"1982","unstructured":"Elliott JM, Grahame-Smith DG (1982) The binding characteristics of [3H]-dihydroergocryptine on intact human platelets. Br J Pharmacol 76(1):121\u2013130","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10936_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5414\/CPP39144","volume":"39","author":"G Micieli","year":"2001","unstructured":"Micieli G, Cavallini A, Marcheselli S, Mailland F, Ambrosoli L, Nappi G (2001) Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis. Int J Clin Pharmacol Ther 39(4):144\u2013151","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"10","key":"10936_CR43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S1474-4422(09)70225-X","volume":"8","author":"A Antonini","year":"2009","unstructured":"Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH (2009) A reassessment of risks and benefits of dopamine agonists in Parkinson\u2019s disease. Lancet Neurol 8(10):929\u2013937. https:\/\/doi.org\/10.1016\/S1474-4422(09)70225-X","journal-title":"Lancet Neurol"},{"issue":"5","key":"10936_CR44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1034\/j.1600-0404.2003.02049.x","volume":"107","author":"A Albanese","year":"2003","unstructured":"Albanese A, Colosimo C (2003) Dihydroergocriptine in Parkinson\u2019s disease: clinical efficacy and comparison with other dopamine agonists. Acta Neurol Scand 107(5):349\u2013355","journal-title":"Acta Neurol Scand"},{"issue":"10","key":"10936_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1055\/s-0031-1297016","volume":"54","author":"E Mailland","year":"2004","unstructured":"Mailland E, Magnani P, Ottillinger B (2004) Alpha-dihydroergocryptine in the long-term therapy of Parkinson\u2019s disease. Arzneimittelforschung 54(10):647\u2013654. https:\/\/doi.org\/10.1055\/s-0031-1297016","journal-title":"Arzneimittelforschung"},{"key":"10936_CR46","volume-title":"Medizinische Chemie","author":"D Steinhilber","year":"2005","unstructured":"Steinhilber D, Schubert M, Roth H (2005) Medizinische Chemie. Deutscher Apotheker Verlag, Stuttgart"},{"issue":"1","key":"10936_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","volume":"280","author":"M Merlos","year":"1997","unstructured":"Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, Garcia-Rafanell J, Forn J (1997) Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther 280(1):114\u2013121","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10936_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1213\/00000539-198409000-00003","volume":"63","author":"RS Matteo","year":"1984","unstructured":"Matteo RS, Lieberman IG, Salanitre E, McDaniel DD, Diaz J (1984) Distribution, elimination, and action of d-tubocurarine in neonates, infants, children, and adults. Anesth Analg 63(9):799\u2013804","journal-title":"Anesth Analg"},{"issue":"1","key":"10936_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/jop.2023.0092","volume":"40","author":"C Cai","year":"2024","unstructured":"Cai C, Youssef AAA, Joshi PH, Varner C, Dudhipala N, Majumdar S (2024) Improved topical ophthalmic natamycin suspension for the treatment of fungal keratitis. J Ocul Pharmacol Ther 40(1):67\u201377. https:\/\/doi.org\/10.1089\/jop.2023.0092","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"10936_CR50","first-page":"1253","volume":"43","author":"K Adams","year":"1993","unstructured":"Adams K, Allen JA, Brooker PC, Jones E, Proudlock RJ, Mailland F, Coppi G (1993) Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivo. Arzneimittelforschung 43(12):1253\u20131257","journal-title":"Arzneimittelforschung"},{"key":"10936_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2239925","volume":"30","author":"A Roy","year":"2023","unstructured":"Roy A, Paul I, Paul T, Hazarika K, Dihidar A, Ray S (2023) An in-silico receptor-pharmacophore based multistep molecular docking and simulation study to evaluate the inhibitory potentials against NS1 of DENV-2. J Biomol Struct Dyn 30:1\u201329. https:\/\/doi.org\/10.1080\/07391102.2023.2239925","journal-title":"J Biomol Struct Dyn"},{"issue":"336","key":"10936_CR52","doi-asserted-by":"publisher","first-page":"199222","DOI":"10.1016\/j.virusres.2023.199222","volume":"15","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Liu J, Hao C, Zhang B, Zhang H (2023) Making sense of flavivirus non-strctural protein 1 in innate immune evasion and inducing tissue-specific damage. Virus Res 15(336):199222. https:\/\/doi.org\/10.1016\/j.virusres.2023.199222","journal-title":"Virus Res"},{"key":"10936_CR53","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1038\/s41467-022-34415-1","volume":"13","author":"B Shu","year":"2022","unstructured":"Shu B, Ooi JSG, Tan AWK et al (2022) CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever. Nat Commun 13:6756. https:\/\/doi.org\/10.1038\/s41467-022-34415-1","journal-title":"Nat Commun"},{"key":"10936_CR54","doi-asserted-by":"publisher","first-page":"104668","DOI":"10.1016\/j.antiviral.2019.104668","volume":"173","author":"D Montes-Grajales","year":"2020","unstructured":"Montes-Grajales D, Puerta-Guardo H, Espinosa DA, Harris E, Caicedo-Torres W, Olivero-Verbel J, Mart\u00ednez-Romero E (2020) In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection. Antiviral Res 173:104668. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104668","journal-title":"Antiviral Res"},{"issue":"6","key":"10936_CR55","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1080\/07391102.2019.1615002","volume":"38","author":"J Vora","year":"2020","unstructured":"Vora J, Patel S, Athar M, Sinha S, Chhabria MT, Jha PC, Shrivastava N (2020) Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds. J Biomol Struct Dyn 38(6):1726\u20131740. https:\/\/doi.org\/10.1080\/07391102.2019.1615002","journal-title":"J Biomol Struct Dyn"},{"issue":"12","key":"10936_CR56","first-page":"898","volume":"35","author":"SQ Zheng","year":"2000","unstructured":"Zheng SQ, Li T, Xuan YX, Lin SZ, Chen LJ, Yan GM (2000) Neuroprotective effect of alpha-dihydroergocryptine depends on activation of nuclear factor kappa B. Yao Xue Xue Bao 35(12):898\u2013901 (in Chinese)","journal-title":"Yao Xue Xue Bao"},{"issue":"2","key":"10936_CR57","doi-asserted-by":"publisher","first-page":"e0010118","DOI":"10.1371\/journal.pntd.0010118","volume":"16","author":"HK Hopkins","year":"2022","unstructured":"Hopkins HK, Traverse EM, Barr KL (2022) Viral Parkinsonism: an underdiagnosed neurological complication of dengue virus infection. PLoS Negl Trop Dis 16(2):e0010118. https:\/\/doi.org\/10.1371\/journal.pntd.0010118","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10936_CR58","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4269\/ajtmh.20-0039","volume":"103","author":"PK Panda","year":"2020","unstructured":"Panda PK, Sharawat IK, Bolia R, Shrivastava Y (2020) Case report: dengue virus-triggered parkinsonism in an adolescent. Am J Trop Med Hyg 103(2):851\u2013854. https:\/\/doi.org\/10.4269\/ajtmh.20-0039","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10936_CR59","doi-asserted-by":"publisher","first-page":"21581","DOI":"10.1038\/s41598-020-78446-4","volume":"10","author":"G Goode-Romero","year":"2020","unstructured":"Goode-Romero G, Winnberg U, Dom\u00ednguez L, Ibarra IA, Vargas R, Winnberg E, Mart\u00ednez A (2020) New information of dopaminergic agents based on quantum chemistry calculations. Sci Rep 10(1):21581. https:\/\/doi.org\/10.1038\/s41598-020-78446-4","journal-title":"Sci Rep"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10936-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10936-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:41:49Z","timestamp":1741956109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10936-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10936"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10936-3","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}